home / stock / verv / verv articles

VERV Articles, Verve Therapeutics Inc. - From 10/31/23

Stock Information
Company Name: Verve Therapeutics Inc.
Stock Symbol: VERV
Market: NASDAQ
Website: vervetx.com
Menu
VERV VERV Quote VERV Short VERV News VERV Articles VERV Message Board
Get VERV Alerts

News, Short Squeeze, Breakout and More Instantly...
Verve and Lilly Relationship Expands to Include Verve's In Vivo Gene Editing Programs Targeting PCSK9 and ANGPTL3 | Benzinga

BOSTON, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Verve Therapeutics, Inc., a clinical-stage biotechnology company pioneering a new approach to the car...
Why TD SYNNEX Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session | Benzinga

Gainers Soleno Therapeutics, Inc. (NASDAQ: SLNO) shares jumped 318.5% to $18.54 after the company released top-line results from randomized withd...

Fisker, Intercept Pharmaceuticals, Immunovant And Other Big Stocks Moving Higher On Tuesday | Benzinga

U.S. stocks traded lower, with the Dow Jones falling around 200 points on Tuesday. Here are some big stocks recording gains in today’s sessio...

Verve to Present Interim Data from the heart-1 Phase 1b Clinical Trial of VERVE-101 in HeFH Patients at the American Heart Association's Scientific Sessions 2023 | Benzinga

BOSTON, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage biotechnology company pioneering a new approach to the care of c...
Verve Therapeutics to Participate in the 2023 Cantor Global Healthcare Conference | Benzinga

BOSTON, Sept. 21, 2023 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage biotechnology company pioneering a new approach to the care of c...

Verve Expands Leadership Team with Appointment of Frederick T. Fiedorek, M.D., as Chief Medical Officer | Benzinga

BOSTON, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage biotechnology company pioneering a new approach to the care of c...

Verve Therapeutics Inc. (NASDAQ:VERV) Short Squeeze 2022-11-07 | Squeeze Report News

Over the past twenty days of trading, Verve Therapeutics Inc. (NASDAQ: VERV), from October 10, 2022 to November 04, 2022 there is a potential Short...
Previous 10 Next 10